Ibutamoren (MK-677): Safety Safety considerations for ibutamoren (MK-677) may include the following: Increased fasting blood glucose levels Potential impact on insulin sensitivity Risk of fluid retention Clinical trials were discontinued early due to concerns about potential cardiovascular effects
Contact your healthcare provider promptly, or seek urgent care if symptoms feel severe, if you have: Vomiting that does not stop Diarrhea that does not go away Inability to keep fluids down Fainting Confusion Severe weakness Very dark urine or not urinating much Fast heartbeat with dehydration symptoms Severe abdominal pain Symptoms that became intense after a dose increase GLP-1 medications can be very helpful for many people, but feeling miserable, unable to eat, unable to drink, or constantly dehydrated is not something to simply push through. FAQ: Electrolytes While Using GLP-1 Can I drink electrolytes every day on Ozempic
For women using GLP-1 therapy, what you eat can amplify or sabotage results
GLP-1 agonists significantly reduced HbA1c, MD=-4.28, 95% CI , -5.06--3.49
Personal Risk Retatrutide injection site reactions are rare but may occur in anyone using this drug
It felt warm and honestly fun
